The Impact of Borderline Quantiferon-TB Gold Plus Results for Latent Tuberculosis Screening under Routine Conditions in a Low-Endemicity Setting. [PDF]
Wikell A +11 more
europepmc +1 more source
Intestinal Helminth Infections and Their Association with QuantiFERON-TB Gold Plus Test Performance in an Endemic Setting, Northwest Ethiopia. [PDF]
Zenebe Y +7 more
europepmc +1 more source
Performance of the T-SPOT.TB test in patients with indeterminate QuantiFERON-TB Gold Plus results: proposal for an algorithm for the diagnosis of Latent Tuberculosis Infection. [PDF]
Pagnoncelli M +4 more
europepmc +1 more source
QuantiFERON-TB Gold Plus with Chemiluminescence Immunoassay: Do We Need a Higher Cutoff? [PDF]
Bisognin F +3 more
europepmc +1 more source
HIV and diabetes impair <i>M. tuberculosis</i>-specific interferon-gamma responses on QuantiFERON-TB Gold Plus testing. [PDF]
Zifodya JS +11 more
europepmc +1 more source
Prevalence, Risk Factors, and Result Features in the Detection of Latent Tuberculosis Infection in Thai Healthcare Workers Using QuantiFERON-TB Gold Plus. [PDF]
Klayut W +9 more
europepmc +1 more source
Comparing patterns of recent and remote Mycobacterium tuberculosis infection determined using the QuantiFERON-TB Gold Plus assay in a high TB burden setting. [PDF]
Amofa-Sekyi M +15 more
europepmc +1 more source
Multiple cytokine analysis based on QuantiFERON-TB gold plus in different tuberculosis infection status: an exploratory study. [PDF]
Zhang L +7 more
europepmc +1 more source
Frequency and Factors of Indeterminate QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold PLUS Test Results in Rheumatic Diseases [PDF]
We compared the results and differences of indeterminate rates between the QuantiFERON-TB Gold In-Tube (QFT-GIT) and QuantiFERON-TB Gold PLUS (QFT-PLUS) tests in patients with rheumatic diseases and analyzed the associated factors. Data of patients with rheumatic diseases who had undergone the QFT-GIT or QFT-PLUS test were used, and information ...
Younhee Park +2 more
exaly +5 more sources

